Irinotecan Accord 20 mg/ml Solution à diluer pour perfusion

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire Rouen, Unicancer

Conditions

Stage III colorectal cancerresected pancreatic adenocarcinoma

Phase 2

Risk-adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOX FRENCH26 – PRODIGE93 - PANACHE02 Trial

RecruitingCTIS2024-519048-33-00

Centre Hospitalier Universitaire Rouenresected pancreatic adenocarcinoma

Start: 2025-11-25Target: 390Updated: 2025-05-28

Phase 3

CIRCULATE III - Tailoring the decision for adjuvant chemotherapy using circulating tumour DNA, in patients with stage III colorectal cancer

Not yet recruitingCTIS2025-521045-24-00

UnicancerStage III colorectal cancer

Target: 240Updated: 2026-04-28